Lizhen Xu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Lizhen Xu has a total of 83 co-authors. Here are the top co-authors by number of shared publications:
- Fan Yang
Kidney Disease Center of the First Affiliated Hospital and Department of Biophysics, Zhejiang University School of Medicine, Hangzhou, China
4 shared publications - Wei Yang
School of Basic Medical Sciences and Forensic Medicine, Hangzhou Medical College 2 , Hangzhou
2 shared publications Aerziguli Aierken
Department of Physiology School of Basic Medical Sciences Xinjiang Medical University Urumqi Xinjiang China
1 shared publicationAiqin Zhu
Kidney Disease Center of the First Affiliated Hospital and Department of Biophysics Zhejiang University School of Medicine Hangzhou Zhejiang China
1 shared publication- Alexander Philipp Benz
Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada
1 shared publication - Alexander Thomas Cohen
Guy's and St Thomas' Hospitals NHS Foundation Trust, King's College London, UK
1 shared publication
Latest Publications
- Open Access
- 27 September 2026
- Published by Wiley in Advanced Science
- p. e77759
An Extracellular Pore‑Targeting Peptide Defines a Designable Allosteric Site in TRPV2
Extracellular pore domains of ion channels are emerging as dynamic regulatory surfaces, but whether they can be rationally targeted to achieve selective channel modulation remains unclear. Here, using an optimized hotspot‐centric design strategy, we developed Depiv2, a structure‐guided peptidic inhibitor of TRPV2 that binds the extracellular pore domain and suppresses channel activity with nanomolar potency and subtype selectivity. Our cryo‐EM structure of the TRPV2–Depiv2 complex showed that peptide binding remodels the pore domain and stabilizes a closed, non‐conductive conformation. Patch‐clamp recordings further revealed that Depiv2 decreases both open probability and single‐channel conductance, indicating inhibition through combined allosteric and permeation‐coupled mechanisms. In cellular and mouse models of pathological cardiac hypertrophy, Depiv2 blunted disease‐associated remodeling. These findings establish the extracellular pore of TRPV2 as a designable allosteric site and illustrate how rational peptide engineering can be used to target extracellular regulatory surfaces in TRP channels.
- 27 September 2026
- Published by Wiley in Advanced Science
- p. e77759
Open AccessAn Extracellular Pore‑Targeting Peptide Defines a Designable Allosteric Site in TRPV2
Extracellular pore domains of ion channels are emerging as dynamic regulatory surfaces, but whether they can be rationally targeted to achieve selective channel modulation remains unclear. Here, using an optimized hotspot‐centric design strategy, we developed Depiv2, a structure‐guided peptidic inhibitor of TRPV2 that binds the extracellular pore domain and suppresses channel activity with nanomolar potency and subtype selectivity. Our cryo‐EM structure of the TRPV2–Depiv2 complex showed that peptide binding remodels the pore domain and stabilizes a closed, non‐conductive conformation. Patch‐clamp recordings further revealed that Depiv2 decreases both open probability and single‐channel conductance, indicating inhibition through combined allosteric and permeation‐coupled mechanisms. In cellular and mouse models of pathological cardiac hypertrophy, Depiv2 blunted disease‐associated remodeling. These findings establish the extracellular pore of TRPV2 as a designable allosteric site and illustrate how rational peptide engineering can be used to target extracellular regulatory surfaces in TRP channels.
- Open Access
- 30 June 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
TRPC4/TRPC5 are critical for neuronal modulation by transcranial focused ultrasound in retrosplenial cortex in male mice
Transcranial focused ultrasound (tFUS) enables non-invasive neuromodulation, yet its underlying molecular mechanisms remain largely elusive. Here, we show that transient receptor potential canonical 4 (TRPC4) and transient receptor potential canonical 5 (TRPC5) channels are critical mediators of tFUS-induced neuronal modulation in the mouse brain. Applying tFUS to the retrosplenial cortex (RSC) in male mice desensitizes mechanical and thermal sensitivity while robustly elicits early growth response 1 (Egr1) expression. Inhibiting these tFUS-induced Egr1 ensembles blocks the somatic sensory effects. Transcriptomic analysis identifies Trpc4 enrichment in tFUS-activated Egr1-positive cells. Both pharmacological inhibition and genetic knockdown of TRPC4 abolish tFUS-mediated sensory modulation. Targeted knockdown further demonstrates that the highly homologous TRPC5 plays a comparable role. In situ proximity ligation assay, co-immunoprecipitation, and live-cell calcium imaging confirm that TRPC4 and TRPC5 form a protein complex in the RSC that facilitates the tFUS response. These findings establish TRPC4/TRPC5 as essential molecular components for tFUS neuromodulation.
- 30 June 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessTRPC4/TRPC5 are critical for neuronal modulation by transcranial focused ultrasound in retrosplenial cortex in male mice
Transcranial focused ultrasound (tFUS) enables non-invasive neuromodulation, yet its underlying molecular mechanisms remain largely elusive. Here, we show that transient receptor potential canonical 4 (TRPC4) and transient receptor potential canonical 5 (TRPC5) channels are critical mediators of tFUS-induced neuronal modulation in the mouse brain. Applying tFUS to the retrosplenial cortex (RSC) in male mice desensitizes mechanical and thermal sensitivity while robustly elicits early growth response 1 (Egr1) expression. Inhibiting these tFUS-induced Egr1 ensembles blocks the somatic sensory effects. Transcriptomic analysis identifies Trpc4 enrichment in tFUS-activated Egr1-positive cells. Both pharmacological inhibition and genetic knockdown of TRPC4 abolish tFUS-mediated sensory modulation. Targeted knockdown further demonstrates that the highly homologous TRPC5 plays a comparable role. In situ proximity ligation assay, co-immunoprecipitation, and live-cell calcium imaging confirm that TRPC4 and TRPC5 form a protein complex in the RSC that facilitates the tFUS response. These findings establish TRPC4/TRPC5 as essential molecular components for tFUS neuromodulation.
- Open Access
- 14 November 2025
- Published by Springer Nature in EMBO Reports
- Vol. 26 (24) , 6325-6345
Rational tuning of temperature sensitivity of the TRPM8 channel
Detecting temperature is crucial for the survival of living organisms. Although the temperature sensitive Transient Receptor Potential Melastatin 8 (TRPM8) channel has been identified as the prototypical cold sensor, the mechanisms by which it detects temperature remain elusive. In this study, we first identify groups of clustered residues that undergo conformational rearrangements between buried and exposed states during cold activation by hydroxyl radical footprinting-mass spectrometry (HRF-MS). By systematically perturbing water-protein interactions at these residues with point mutations that change side chain hydrophobicity (SCH), we achieve rational tuning of temperature sensitivity in this channel. Specifically, mutations with the clearest impacts on TRPM8 cold sensitivity are clustered in the MHR1-3 domains, where the protein of isolated MHR1-3 domains also exhibits clear conformational rearrangements in response to cold. Guided by this mechanism, we rationally edit the Trpm8 gene in mice, introducing a single point mutation to render them insensitive to coldness.
- 14 November 2025
- Published by Springer Nature in EMBO Reports
- Vol. 26 (24) , 6325-6345
Open AccessRational tuning of temperature sensitivity of the TRPM8 channel
Detecting temperature is crucial for the survival of living organisms. Although the temperature sensitive Transient Receptor Potential Melastatin 8 (TRPM8) channel has been identified as the prototypical cold sensor, the mechanisms by which it detects temperature remain elusive. In this study, we first identify groups of clustered residues that undergo conformational rearrangements between buried and exposed states during cold activation by hydroxyl radical footprinting-mass spectrometry (HRF-MS). By systematically perturbing water-protein interactions at these residues with point mutations that change side chain hydrophobicity (SCH), we achieve rational tuning of temperature sensitivity in this channel. Specifically, mutations with the clearest impacts on TRPM8 cold sensitivity are clustered in the MHR1-3 domains, where the protein of isolated MHR1-3 domains also exhibits clear conformational rearrangements in response to cold. Guided by this mechanism, we rationally edit the Trpm8 gene in mice, introducing a single point mutation to render them insensitive to coldness.
- Open Access
- 1 July 2021
- Published by Springer Nature in BMC Pediatrics
- Vol. 21 (1) , 1-7
Two novel mutations in TCIRG1 induced infantile malignant osteopetrosis: a case report
Background: Infantile malignant osteopetrosis (IMO) is a rare autosomal recessive disease characterized by a higher bone density in bone marrow caused by the dysfunction of bone resorption. Clinically, IMO can be diagnosed with medical examination, bone mineral density test and whole genome sequencing. Case presentation: We present the case of a 4-month-old male infant with abnormal skull development, hypocalcemia and premature closure of the cranial sutures. Due to the hyper bone density showed by his radiographic examination, which are characteristic patterns of IMO, we speculated that he might be an IMO patient. In order to confirm this diagnosis, a high-precision whole exome sequencing of the infant and his parents was performed. The analysis of high-precision whole exome sequencing results lead to the identification of two novel heterozygous mutations c.504-1G > C (a splicing site mutation) and c.1371delC (p.G458Afs*70, a frameshift mutation) in gene TCIRG1 derived from his parents. Therefore, we propose that there is a close association between these two mutations and the onset of IMO. Conclusions: To date, these two novel mutations in gene TCIRG1 have not been reported in the reference gene database of Chinese population. These variants have likewise not been reported outside of China in the Genome Aggregation Database (gnomAD). Our case suggests that the use of whole exome sequencing to detect these two mutations will improve the identification and early diagnosis of IMO, and more specifically, the identification of homozygous individuals with TCIRG1 gene mutation. We propose that these mutations in gene TCIRG1 could be a novel therapeutic target for the IMO in the future.
- 1 July 2021
- Published by Springer Nature in BMC Pediatrics
- Vol. 21 (1) , 1-7
Open AccessTwo novel mutations in TCIRG1 induced infantile malignant osteopetrosis: a case report
Background: Infantile malignant osteopetrosis (IMO) is a rare autosomal recessive disease characterized by a higher bone density in bone marrow caused by the dysfunction of bone resorption. Clinically, IMO can be diagnosed with medical examination, bone mineral density test and whole genome sequencing. Case presentation: We present the case of a 4-month-old male infant with abnormal skull development, hypocalcemia and premature closure of the cranial sutures. Due to the hyper bone density showed by his radiographic examination, which are characteristic patterns of IMO, we speculated that he might be an IMO patient. In order to confirm this diagnosis, a high-precision whole exome sequencing of the infant and his parents was performed. The analysis of high-precision whole exome sequencing results lead to the identification of two novel heterozygous mutations c.504-1G > C (a splicing site mutation) and c.1371delC (p.G458Afs*70, a frameshift mutation) in gene TCIRG1 derived from his parents. Therefore, we propose that there is a close association between these two mutations and the onset of IMO. Conclusions: To date, these two novel mutations in gene TCIRG1 have not been reported in the reference gene database of Chinese population. These variants have likewise not been reported outside of China in the Genome Aggregation Database (gnomAD). Our case suggests that the use of whole exome sequencing to detect these two mutations will improve the identification and early diagnosis of IMO, and more specifically, the identification of homozygous individuals with TCIRG1 gene mutation. We propose that these mutations in gene TCIRG1 could be a novel therapeutic target for the IMO in the future.
- Open Access
- 7 December 2020
- Published by Springer Nature in Human Genomics
- Vol. 14 (1) , 1-8
KVarPredDB: a database for predicting pathogenicity of missense sequence variants of keratin genes associated with genodermatoses
Background: Germline variants of ten keratin genes (K1,K2,K5,K6A,K6B,K9,K10,K14,K16, andK17) have been reported for causing different types of genodermatoses with an autosomal dominant mode of inheritance. Among all the variants of these ten keratin genes, most of them are missense variants. Unlike pathogenic and likely pathogenic variants, understanding the clinical importance of novel missense variants or variants of uncertain significance (VUS) is the biggest challenge for clinicians or medical geneticists. Functional characterization is the only way to understand the clinical association of novel missense variants or VUS but it is time consuming, costly, and depends on the availability of patient’s samples. Existing databases report the pathogenic variants of the keratin genes, but never emphasize the systematic effects of these variants on keratin protein structure and genotype-phenotype correlation.Results: To address this need, we developed a comprehensive database KVarPredDB, which contains information of all ten keratin genes associated with genodermatoses. We integrated and curated 400 reported pathogenic missense variants as well as 4629 missense VUS. KVarPredDB predicts the pathogenicity of novel missense variants as well as to understand the severity of disease phenotype, based on four criteria; firstly, the difference in physico-chemical properties between the wild type and substituted amino acids; secondly, the loss of inter/intra-chain interactions; thirdly, evolutionary conservation of the wild type amino acids and lastly, the effect of the substituted amino acids in the heptad repeat. Molecular docking simulations based on resolved crystal structures were adopted to predict stability changes and get the binding energy to compare the wild type protein with the mutated one. We use this basic information to determine the structural and functional impact of novel missense variants on the keratin coiled-coil heterodimer. KVarPredDB was built under the integrative web application development framework SSM (SpringBoot, Spring MVC, MyBatis) and implemented in Java, Bootstrap, React-mutation-mapper, MySQL, Tomcat. The website can be accessed throughhttp://bioinfo.zju.edu.cn/KVarPredDB. The genomic variants and analysis results are freely available under the Creative Commons license.Conclusions: KVarPredDB provides an intuitive and user-friendly interface with computational analytical investigation for each missense variant of the keratin genes associated with genodermatoses.
- 7 December 2020
- Published by Springer Nature in Human Genomics
- Vol. 14 (1) , 1-8
Open AccessKVarPredDB: a database for predicting pathogenicity of missense sequence variants of keratin genes associated with genodermatoses
Background: Germline variants of ten keratin genes (K1,K2,K5,K6A,K6B,K9,K10,K14,K16, andK17) have been reported for causing different types of genodermatoses with an autosomal dominant mode of inheritance. Among all the variants of these ten keratin genes, most of them are missense variants. Unlike pathogenic and likely pathogenic variants, understanding the clinical importance of novel missense variants or variants of uncertain significance (VUS) is the biggest challenge for clinicians or medical geneticists. Functional characterization is the only way to understand the clinical association of novel missense variants or VUS but it is time consuming, costly, and depends on the availability of patient’s samples. Existing databases report the pathogenic variants of the keratin genes, but never emphasize the systematic effects of these variants on keratin protein structure and genotype-phenotype correlation.Results: To address this need, we developed a comprehensive database KVarPredDB, which contains information of all ten keratin genes associated with genodermatoses. We integrated and curated 400 reported pathogenic missense variants as well as 4629 missense VUS. KVarPredDB predicts the pathogenicity of novel missense variants as well as to understand the severity of disease phenotype, based on four criteria; firstly, the difference in physico-chemical properties between the wild type and substituted amino acids; secondly, the loss of inter/intra-chain interactions; thirdly, evolutionary conservation of the wild type amino acids and lastly, the effect of the substituted amino acids in the heptad repeat. Molecular docking simulations based on resolved crystal structures were adopted to predict stability changes and get the binding energy to compare the wild type protein with the mutated one. We use this basic information to determine the structural and functional impact of novel missense variants on the keratin coiled-coil heterodimer. KVarPredDB was built under the integrative web application development framework SSM (SpringBoot, Spring MVC, MyBatis) and implemented in Java, Bootstrap, React-mutation-mapper, MySQL, Tomcat. The website can be accessed throughhttp://bioinfo.zju.edu.cn/KVarPredDB. The genomic variants and analysis results are freely available under the Creative Commons license.Conclusions: KVarPredDB provides an intuitive and user-friendly interface with computational analytical investigation for each missense variant of the keratin genes associated with genodermatoses.
- Open Access
- 6 January 2020
- Published by Cold Spring Harbor Laboratory in bioRxiv
An unorthodox mechanism underlying voltage sensitivity of TRPV1 ion channel
While the capsaicin receptor TRPV1 channel is a polymodal nociceptor for heat, capsaicin, and proton, the channel’s responses to each of these stimuli are profoundly regulated by membrane potential, damping or even prohibiting its response at negative voltages and amplifying its response at positive voltages. Though voltage sensitivity plays an important role is shaping pain responses, how voltage regulates TRPV1 activation remains unknown. Here we showed that the voltage sensitivity of TRPV1 does not originate from the S4 segment like classic voltage-gated ion channels; instead, outer pore acidic residues directly partake in voltage-sensitive activation, with their negative charges collectively constituting the observed gating charges. Voltage-sensitive outer pore movement is titratable by extracellular pH and is allosterically coupled to channel activation, likely by influencing the upper gate in the ion selectivity filter. Elucidating this unorthodox voltage-gating process provides a mechanistic foundation for understanding polymodal gating and opens the door to novel approaches regulating channel activity for pain managements.
- 6 January 2020
- Published by Cold Spring Harbor Laboratory in bioRxiv
Open AccessAn unorthodox mechanism underlying voltage sensitivity of TRPV1 ion channel
While the capsaicin receptor TRPV1 channel is a polymodal nociceptor for heat, capsaicin, and proton, the channel’s responses to each of these stimuli are profoundly regulated by membrane potential, damping or even prohibiting its response at negative voltages and amplifying its response at positive voltages. Though voltage sensitivity plays an important role is shaping pain responses, how voltage regulates TRPV1 activation remains unknown. Here we showed that the voltage sensitivity of TRPV1 does not originate from the S4 segment like classic voltage-gated ion channels; instead, outer pore acidic residues directly partake in voltage-sensitive activation, with their negative charges collectively constituting the observed gating charges. Voltage-sensitive outer pore movement is titratable by extracellular pH and is allosterically coupled to channel activation, likely by influencing the upper gate in the ion selectivity filter. Elucidating this unorthodox voltage-gating process provides a mechanistic foundation for understanding polymodal gating and opens the door to novel approaches regulating channel activity for pain managements.
- 1 January 2006
- Published by Springer Nature in Biotechnology Letters
- Vol. 28 (2) , 99-105
Genome-wide Analysis of the Expression Profile of Saccharomyces cerevisiae in Response to Treatment with the Plant Isoflavone, Wighteone, as a Potential Antifungal Agent
The limitations of currently available antifungal agents and the rapid emergence of drug-resistant strains necessitate more efficient approaches to screening and developing novel antifungal drugs. The antifungal activity of the natural products of a series of plants was evaluated and wighteone, 5, 7, 4′–trihydroxy–6–(γ,γ-dimethylallyl)isoflavone showed excellent anti-yeast activity (MIC against Saccharomyces cerevisiae was 4 μg/ml). Transcriptome profiling of wighteone-treated S. cerevisiae indicated that wighteone is different from commonly used antifungal compounds in its mode of action.
- 1 January 2006
- Published by Springer Nature in Biotechnology Letters
- Vol. 28 (2) , 99-105
Genome-wide Analysis of the Expression Profile of Saccharomyces cerevisiae in Response to Treatment with the Plant Isoflavone, Wighteone, as a Potential Antifungal Agent
The limitations of currently available antifungal agents and the rapid emergence of drug-resistant strains necessitate more efficient approaches to screening and developing novel antifungal drugs. The antifungal activity of the natural products of a series of plants was evaluated and wighteone, 5, 7, 4′–trihydroxy–6–(γ,γ-dimethylallyl)isoflavone showed excellent anti-yeast activity (MIC against Saccharomyces cerevisiae was 4 μg/ml). Transcriptome profiling of wighteone-treated S. cerevisiae indicated that wighteone is different from commonly used antifungal compounds in its mode of action.